How big is the healthcare revenue cycle management industry?

The global healthcare revenue cycle management market size is expected to increase USD 517.31 billion by 2033 from USD 158.17 billion in 2023. Read More

What will be the CAGR of global healthcare revenue cycle management industry?

The global healthcare revenue cycle management market will register growth rate of 12.58% between 2024 and 2033. Read More

Who are the prominent players operating in the healthcare revenue cycle management market?

The major players operating in the healthcare revenue cycle management market are Allscripts Healthcare, LLC, Dell Technologies, Athenahealth, AGS Health Inc., Experion Information Solutions, Inc., CareCloud, Inc., Cerner Corporation, Change Healthcare, Cognizant, Conifer Health Solutions, LLC., Medical Information Technologies, Inc., McKesson Corporation, Optum, R1 RCM, Inc., SSI Group Formativ Health and Others. Read More

Which is the driving factor of the healthcare revenue cycle management market?

The reduced costs and delays linked with denied claims drives the healthcare revenue cycle management market. Read More

Which region will lead the global healthcare revenue cycle management market?

North America region will lead the global healthcare revenue cycle management market during the forecast period 2024 to 2033. Read More

Healthcare Revenue Cycle Management Market Size, Share, and Trends 2024 to 2033

Healthcare Revenue Cycle Management Market (By Product Type: Integrated, Standalone; By Function Type: Claims and Denial Management, Medical Coding and Billing, Eligibility Verification, Payment Remittance, Others; By Deployment Type: On-premise, Cloud-based; By End-user: Hospitals, Physician Office, Diagnostic Labs and Ambulatory Surgical Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Last Updated : May 2024
Report Code : 4236
Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare Revenue Cycle Management Market

5.1. COVID-19 Landscape: Healthcare Revenue Cycle Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare Revenue Cycle Management Market, By Product Type

8.1. Healthcare Revenue Cycle Management Market Revenue and Volume Forecast, by Product Type, 2024-2033

8.1.1. Integrated

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Standalone

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Healthcare Revenue Cycle Management Market, By Function Type

9.1. Healthcare Revenue Cycle Management Market Revenue and Volume Forecast, by Function Type, 2024-2033

9.1.1. Claims and Denial Management

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Medical Coding and Billing

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Eligibility Verification

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Payment Remittance

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Healthcare Revenue Cycle Management Market, By Deployment Type

10.1. Healthcare Revenue Cycle Management Market Revenue and Volume Forecast, by Deployment Type, 2024-2033

10.1.1. On-premise

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Cloud-based

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Healthcare Revenue Cycle Management Market, By End-user

11.1. Healthcare Revenue Cycle Management Market Revenue and Volume Forecast, by End-user, 2024-2033

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Physician Office

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. Diagnostic Labs and Ambulatory Surgical Centers

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

11.1.4. Others

11.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Healthcare Revenue Cycle Management Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.1.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.1.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.1.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.1.5.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.1.5.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.1.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.1.6.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.1.6.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.1.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.2.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.2.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.2.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.2.5.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.2.5.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.2.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.2.6.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.2.6.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.2.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.2.7.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.2.7.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.2.7.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.2.8.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.2.8.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.2.8.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.3.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.3.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.3.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.3.5.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.3.5.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.3.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.3.6.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.3.6.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.3.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.3.7.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.3.7.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.3.7.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.3.8.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.3.8.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.3.8.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.4.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.4.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.4.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.4.5.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.4.5.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.4.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.4.6.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.4.6.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.4.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.4.7.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.4.7.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.4.7.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.4.8.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.4.8.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.4.8.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.5.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.5.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.5.5.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.5.5.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.5.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.5.6.2. Market Revenue and Volume Forecast, by Function Type (2021-2033)

12.5.6.3. Market Revenue and Volume Forecast, by Deployment Type (2021-2033)

12.5.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)

Chapter 13. Company Profiles

13.1. Allscripts Healthcare, LLC

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Dell Technologies

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Athenahealth

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. AGS Health Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Experion Information Solutions, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. CareCloud, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Cerner Corporation

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Change Healthcare

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Cognizant

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Conifer Health Solutions, LLC.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

We use cookies to improve your experience

Healthcare Revenue Cycle Management Market Size, Report By 2033

List of Contents